Cure Pharmaceutical on Tuesday announced it will acquire privately held Sera Labs in Sherman Oaks for $20 million.

Oxnard-based Cure, a drug delivery developer which trades on the over-the-counter market, said the $20 million will consist of $19 million in Cure stock at a valuation of $2...

Join our Membership to get the full story.

Are you a current Member? Sign In